Decision of the EEA Joint Committee No 266/2023 of 27 October 2023 amending Annex... (22024D1148)
    EU - Internationale Abkommen
    2024/1148
    16.5.2024

    DECISION OF THE EEA JOINT COMMITTEE No 266/2023

    of 27 October 2023

    amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1148]

    THE EEA JOINT COMMITTEE,
    Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
    Whereas:
    (1) Commission Implementing Regulation (EU) 2023/1078 of 2 June 2023 approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 1 ) is to be incorporated into the EEA Agreement.
    (2) Commission Implementing Regulation (EU) 2023/1079 of 2 June 2023 approving (13Z)-hexadec-13-en-11-yn-1-yl acetate as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 2 ) is to be incorporated into the EEA Agreement.
    (3) Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 3 ) is to be incorporated into the EEA Agreement.
    (4) Commission Implementing Decision (EU) 2023/1085 of 2 June 2023 postponing the expiry date of the approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 4 ) is to be incorporated into the EEA Agreement.
    (5) Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 5 ) is to be incorporated into the EEA Agreement.
    (6) Commission Implementing Decision (EU) 2023/1087 of 2 June 2023 postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 6 ) is to be incorporated into the EEA Agreement.
    (7) Commission Implementing Decision (EU) 2023/1088 of 2 June 2023 postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 7 ) is to be incorporated into the EEA Agreement.
    (8) Commission Implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 8 ) is to be incorporated into the EEA Agreement.
    (9) Annex II to the EEA Agreement should therefore be amended accordingly,
    HAS ADOPTED THIS DECISION:

    Article 1

    The following points are inserted after point 12zzzzzzzzzd (Commission Implementing Regulation (EU) 2023/680) of Chapter XV of Annex II to the EEA Agreement:
    ‘12zzzzzzzzze.
    32023 R 1078 : Commission Implementing Regulation (EU) 2023/1078 of 2 June 2023 approving ozone generated from oxygen as an active substance for use in biocidal products of product-types 2, 4, 5 and 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 7 ).
    12zzzzzzzzzf.
    32023 R 1079 : Commission Implementing Regulation (EU) 2023/1079 of 2 June 2023 approving (13Z)-hexadec-13-en-11-yn-1-yl acetate as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 11 ).
    12zzzzzzzzzg.
    32023 D 1084 : Commission Implementing Decision (EU) 2023/1084 of 1 June 2023 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product A-Quasan in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 91 ).
    12zzzzzzzzzh.
    32023 D 1085 : Commission Implementing Decision (EU) 2023/1085 of 2 June 2023 postponing the expiry date of the approval of Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 94 ).
    12zzzzzzzzzi.
    32023 D 1086 : Commission Implementing Decision (EU) 2023/1086 of 2 June 2023 postponing the expiry date of the approval of metofluthrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 96 ).
    12zzzzzzzzzj.
    32023 D 1087 : Commission Implementing Decision (EU) 2023/1087 of 2 June 2023 postponing the expiry date of the approval of lambda-cyhalothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 98 ).
    12zzzzzzzzzk.
    32023 D 1088 : Commission Implementing Decision (EU) 2023/1088 of 2 June 2023 postponing the expiry date of the approval of deltamethrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 144, 5.6.2023, p. 100 ).
    12zzzzzzzzzl.
    32023 D 1097 : Commission Implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 146, 6.6.2023, p. 27 ).’

    Article 2

    The texts of Implementing Regulations (EU) 2023/1078 and (EU) 2023/1079 and Implementing Decisions (EU) 2023/1084, (EU) 2023/1085, (EU) 2023/1086, (EU) 2023/1087, (EU) 2023/1088 and (EU) 2023/1097 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

    Article 3

    This Decision shall enter into force on 28 October 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

    Article 4

    This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
    Done at Brussels, 27 October 2023.
    For the EEA Joint Committee
    The President
    Pascal SCHAFHAUSER
    ( 1 )    OJ L 144, 5.6.2023, p. 7 .
    ( 2 )    OJ L 144, 5.6.2023, p. 11 .
    ( 3 )    OJ L 144, 5.6.2023, p. 91 .
    ( 4 )    OJ L 144, 5.6.2023, p. 94 .
    ( 5 )    OJ L 144, 5.6.2023, p. 96 .
    ( 6 )    OJ L 144, 5.6.2023, p. 98 .
    ( 7 )    OJ L 144, 5.6.2023, p. 100 .
    ( 8 )    OJ L 146, 6.6.2023, p. 27 .
    ( *1 )   No constitutional requirements indicated.
    ELI: http://data.europa.eu/eli/dec/2024/1148/oj
    ISSN 1977-0677 (electronic edition)
    Markierungen
    Leseansicht
    Verwendung von Cookies.

    Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

    Akzeptieren